A novel transmembrane serine protease (TMPRSS3) overexpressed in pancreatic cancer

Cancer Res. 2000 May 15;60(10):2602-6.

Abstract

We report the characterization of a novel serine protease of the chymotrypsin family, recently isolated by cDNA-representational difference analysis, as a gene overexpressed in pancreatic cancer. The 2.3-kb mRNA of the gene, named TMPRSS3, is strongly expressed in a subset of pancreatic cancer and various other cancer tissues, and its expression correlates with the metastatic potential of the clonal SUIT-2 pancreatic cancer cell lines. The deduced polypeptide sequence consists of 437 amino acids and exhibits all of the structural features characteristic of serine proteases with trypsin-like activity. TMPRSS3 is membrane bound with a NH2-terminal signal-anchor sequence and a glycosylated extracellular region containing the serine protease domain. Thus, TMPRSS3 is a novel membrane-bound serine protease overexpressed in cancer, which may be of importance for processes involved in metastasis formation and tumor invasion.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Base Sequence
  • Blotting, Western
  • Chromosome Mapping
  • Gene Expression Regulation, Enzymologic
  • Gene Expression Regulation, Neoplastic
  • Gene Library
  • Humans
  • Membrane Proteins*
  • Molecular Sequence Data
  • Neoplasm Proteins*
  • Pancreatic Neoplasms / enzymology*
  • Pancreatic Neoplasms / genetics
  • Peptide Library
  • Serine Endopeptidases / biosynthesis*
  • Serine Endopeptidases / genetics*
  • Tumor Cells, Cultured

Substances

  • Membrane Proteins
  • Neoplasm Proteins
  • Peptide Library
  • Serine Endopeptidases
  • TMPRSS3 protein, human